Uterine leiomyosarcoma: does the primary surgical procedure matter?

Area of Science:

• Gynecologic Oncology
• Surgical Oncology
• Pathology

Background:

• Uterine leiomyosarcoma (LMS) presents a poor prognosis, often diagnosed late.
• Preoperative differentiation between LMS and benign uterine leiomyoma remains challenging.
• This diagnostic difficulty can lead to suboptimal surgical interventions.

Purpose of the Study:

• To investigate the impact of surgical procedures involving tumor injury on the prognosis of early-stage uterine leiomyosarcoma.
• To compare survival outcomes between total hysterectomy and procedures that entail tumor morcellation or resection.

Main Methods:

• Retrospective review of demographic and clinical data for stage I LMS patients (1969-2005).
• Patients were categorized into two groups: total hysterectomy (Group A) and procedures with tumor injury (Group B).
• Survival rates and recurrence were analyzed using Kaplan-Meier curves and Cox proportional hazards models.

Main Results:

• Group A (total hysterectomy) demonstrated significantly better survival rates (P=0.04) and recurrence rates (P=0.03) compared to Group B.
• Survival in Group A was 2.8 times better than in Group B, a finding robust to adjustments for age, menopausal status, and radiotherapy.
• No significant differences were observed between groups regarding age, menopausal status, gravidity, parity, or radiotherapy use.

Conclusions:

• Primary surgery involving tumor injury in stage I LMS appears to be linked to a worse prognosis.
• Total hysterectomy as an initial surgical approach is associated with improved survival outcomes for early-stage LMS.
• These findings underscore the importance of surgical technique in managing uterine leiomyosarcoma.